Prof. Lütfi Özkan is a Professor of Radiation Oncology with a distinguished academic and clinical career. He earned his professorship in Radiation Oncology from Uludağ University in 2009 and has continued to advance patient care and oncology practice. Since 2023 he has been affiliated with Acıbadem Health Group, where he contributes his expertise to multidisciplinary cancer treatment, clinical programs, and education. Known for a patient-centered approach and commitment to evidence-based care, he combines deep clinical knowledge with ongoing engagement in professional development and collaboration within the oncology community.
Education
- 2009 Uludag University / Radiation Oncology / Professor
- 2002 Uludag University / Radiation Oncology / Associate Professor
- 1991 Sisli Etfal Training and Research Hospital Radiation Oncology
- 1985 Akdeniz University Faculty of Medicine
Experience
- 2023 Acibadem Health Group
- 2018 – 2023 Ceylan Internatiaonal Hospital / Specialist Doctor
- 2015 – 2018 Denizli Private Health Hospital / Specialist Dr.
- 2009 – 2015 UÜTF Department of Radiation Oncology / Prof. Dr.
- 2005 – 2009 UÜTF Department of Radiation Oncology / Assoc. Dr.
- 2004 – 2005 Denizli Onkomer Private Oncology Center / Specialist Dr.
- 1996 – 2004 UÜTF Department of Radiation Oncology / Assoc. Assoc. Prof. Dr.
- 2000 University of Kentucky / Fellow
- 1995 – 1996 UÜTF Department of Radiation Oncology / Specialist Dr.
- 1991 – 1995 SB Sisli Etfal Hospital, Radiation Oncology / Chief Assistant
- 1987 – 1991 SB Sisli Etfal Hospital, Radiation Oncology / Research Assistant
- 1985 – 1987 Siirt State Hospital (Compulsory Service) / General Practitioner Dr.
Publications
- Carcinoma originating from aberrant breast tissue. A case report and review of the literature
Tumori 94(3):440-3 (2008). Cetintas S.K., Turan-Ozdemir S, Topal U, Kurt M, Gokgoz S, Saraydaroglu O, Ozkan L. - Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer
Hepatogastroenterology 55(85):1158-63 (2008). Kurt M, Ozkan L, Kurt E, Cetintas SK, Aygun S, Ercan I, Yilmazlar T, Memik F. - Successful spontaneous pregnancy in a patient with rectal carcinoma treated with pelvic radiotherapy and concurrent chemotherapy: the unique role of laparoscopic lateral ovary transposition
Eur J Gyn Oncol 28 (5): 408-410 (2007). Kurt M, Uncu G, Cetintas SK, Kucuk N, Guler S, Ozkan L - Synchronous breast cancer in spouses
Tumori 92 (3): 244-245 (2006). Cetintas S.K., Kurt M, Gokgoz S, Ozkan L, Engin K, Tasdelen I - Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer
Tumori 92 (6): 481-486 (2006). Kurt E, Kurt M, Kanat O, Cetintas SK, Aygun S, Palazoglu J, Ozkan L, Evrensel T, Kaya E, Manavoglu O, - Factors influencing axillary node metastasis in breast cancer
Tumori 92 (5): 416-422 (2006). Cetintas SK, Kurt M, Ozkan L, Engin K, Gokgoz S, Tasdelen I - Gastric metastasis of signet ring cell carcinoma of the breast?
Saudi Medical Journal, 27 (2), 259-261 (2006). Cetintas SK, Kurt M, Ozkan L, et al. - Preoperative chemoradiotherapy in patients with locally advanced rectal cancer
Hepato-Gastroenterology, 52,1095-1100 (2005). Kurt M., L. Ozkan, S.K. Cetintas, I. Ercan, A. Zorluoglu, S. Gurel, F. Memik, K. Engin, - Postoperative concomittant chemoradiotherapy in patients with locally advanced rectal cancer
Hepato-Gastroenterology, 52(65), 1411-1415 (2005). Kurt M., L. Ozkan, T. Yilmazlar, I. Ercan, A. Zorluoglu, F. Memik, K. Engin, - Successful salvage therapy of resistant gestational throblastic disease with etoposide, methotrexate, actinomycin-d, etoposide, cisplatin (EMA/EP)
Arch Gynecol Obstet 2004, 269, 159-160 Bilgin T., H. Ozan, S. Ozuysal, L. Ozkan,
